Apryl
9 known investors
Apryl (Progyny Global) offers a fertility benefits platform that connects employees with fertility experts, clinics, and treatments including IVF, egg and sperm freezing, surrogacy, adoption, and menopause management. It serves companies as an employee benefit to support talent attraction, retention, and DEI strategies, with coverage across Europe, Asia, and Australia.
Investors · 9
AFI VenturesParis · $108K – $550K
AuxxoBerlin
Jazzya InvestmentsAlcobendasvia Martin Varsavsky · inferred
Myelin VCMontevideo · $250K – $1M
Atlantic Labsreported · 2 sourcesBerlin · $108K – $540K
Breegareported · 2 sourcesLondon · $540K – $16.2M
Crista Galli Venturesreported · 2 sourcesLondon
WestTech Venturesreported · 2 sourcesBerlin · $54K – $108K
Also in the syndicate · 1
Alliance For Impact Ventures
Funding
SEC filings, press & company announcements- Undisclosed amountseed fundingApr 2022 · 3 sources
Breega (lead), Alliance For Impact Ventures, Atlantic Labs, Crista Galli Ventures, Myelin VC, Westtech Ventures
Source ↗
Source: company announcements and press reports — follow each round's link for the claim.
In the news
Frequently asked questions
- What does Apryl do?
- Apryl (Progyny Global) offers a fertility benefits platform that connects employees with fertility experts, clinics, and treatments including IVF, egg and sperm freezing, surrogacy, adoption, and menopause management. It serves companies as an employee benefit to support talent attraction, retention, and DEI strategies, with coverage across Europe, Asia, and Australia.
- Who are Apryl's investors?
- Apryl's investors include AFI Ventures, Auxxo, Jazzya Investments, Myelin VC, Atlantic Labs, Breega, Crista Galli Ventures, WestTech Ventures.